Amedeo Smart

Free Medical Literature Service



Alzheimer's Disease

  Free Subscription


4 Alzheimers Dement
1 Biol Psychiatry
1 BMC Geriatr
1 Brain
1 Exp Neurol
10 J Alzheimers Dis
2 J Neurochem
3 J Neurol
2 J Neurol Neurosurg Psychiatry
1 J Neurosci
1 Nat Med
1 Nat Rev Neurol
1 Nervenarzt
1 Neurobiol Aging
3 Neurochem Res
1 Neurologia (Engl Ed)

    Alzheimers Dement

  1. SCHINDLER SE, Li Y, Li M, Despotis A, et al
    Using Alzheimer's disease blood tests to accelerate clinical trial enrollment.
    Alzheimers Dement. 2022 Aug 7. doi: 10.1002/alz.12754.
    >> Share

  2. OLCHANSKI N, Daly AT, Zhu Y, Breslau R, et al
    Alzheimer's disease medication use and adherence patterns by race and ethnicity.
    Alzheimers Dement. 2022 Aug 8. doi: 10.1002/alz.12753.
    >> Share

  3. LANGBAUM JB, Zissimopoulos J, Au R, Bose N, et al
    Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.
    Alzheimers Dement. 2022 Aug 10. doi: 10.1002/alz.12737.
    >> Share

  4. PALMQVIST S, Stomrud E, Cullen N, Janelidze S, et al
    An accurate fully automated panel of plasma biomarkers for Alzheimer's disease.
    Alzheimers Dement. 2022 Aug 11. doi: 10.1002/alz.12751.
    >> Share

    Biol Psychiatry

  5. MA YH, Chen HS, Liu C, Feng QS, et al
    Association of Long-term Exposure to Ambient Air Pollution With Cognitive Decline and Alzheimer's Disease-Related Amyloidosis.
    Biol Psychiatry. 2022 May 18. pii: S0006-3223(22)01255.
    >> Share

    BMC Geriatr

  6. INSKIP MJ, Mavros Y, Sachdev PS, Hausdorff JM, et al
    Promoting independence in Lewy body dementia through exercise: the PRIDE study.
    BMC Geriatr. 2022;22:650.
    >> Share


  7. COURSE MM, Gudsnuk K, Keene CD, Bird TD, et al
    Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.
    Brain. 2022 Aug 11. pii: 6660735. doi: 10.1093.
    >> Share

    Exp Neurol

  8. GOMES P, Tzouanou F, Skolariki K, Iakovou AV, et al
    Extracellular vesicles and Alzheimer's disease in the novel era of Precision Medicine: Implications for disease progression, diagnosis and treatment.
    Exp Neurol. 2022 Aug 8:114183. doi: 10.1016/j.expneurol.2022.114183.
    >> Share

    J Alzheimers Dis

  9. STOILJKOVIC M, Gutierrez KO, Kelley C, Horvath TL, et al
    TREM2 Deficiency Disrupts Network Oscillations Leading to Epileptic Activity and Aggravates Amyloid-beta-Related Hippocampal Pathophysiology in Mice.
    J Alzheimers Dis. 2022;88:837-847.
    >> Share

  10. MABROUK R, Gotkiewicz M, Rauramaa T, Tanila H, et al
    DAPI (4',6-diamidino-2-phenylindole) Stains Compact Amyloid Plaques.
    J Alzheimers Dis. 2022;88:949-955.
    >> Share

  11. LORETO F, Fitzgerald A, Golemme M, Gunning S, et al
    Prevalence of Depressive Symptoms in a Memory Clinic Cohort: A Retrospective Study.
    J Alzheimers Dis. 2022;88:1179-1187.
    >> Share

  12. NOVOTNY JS, Gonzalez-Rivas JP, Vassilaki M, Krell-Roesch J, et al
    Natural Pattern of Cognitive Aging.
    J Alzheimers Dis. 2022;88:1147-1155.
    >> Share

  13. AGUILAR-CALVO P, Sevillano AM, Rasool S, Cao KJ, et al
    Noninvasive Antemortem Detection of Retinal Prions by a Fluorescent Tracer.
    J Alzheimers Dis. 2022;88:1137-1145.
    >> Share

  14. CANARIO E, Chen D, Han Y, Niu H, et al
    Global Network Analysis of Alzheimer's Disease with Minimum Spanning Trees.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD215573. doi: 10.3233/JAD-215573.
    >> Share

  15. PEREZ SD, Phillips JS, Norise C, Kinney NG, et al
    Neuropsychological and Neuroanatomical Features of Patients with Behavioral/Dysexecutive Variant Alzheimer's disease (AD): A Comparison to Behavioral Variant Frontotemporal Dementia and Amnestic AD Groups.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD215728. doi: 10.3233/JAD-215728.
    >> Share

  16. HOFFMANN CM, Nianogo RA, Yaffe K, Rosenwohl-Mack A, et al
    Importance of Accounting for Regional Differences in Modifiable Risk Factors for Alzheimer's Disease and Related Dementias: The Case for Tailored Interventions.
    J Alzheimers Dis. 2022 Jul 30. pii: JAD220278. doi: 10.3233/JAD-220278.
    >> Share

  17. SOARES JZ, Valeur J, Saltyte Benth J, Knapskog AB, et al
    Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD220407. doi: 10.3233/JAD-220407.
    >> Share

  18. TAHAMI MONFARED AA, Stern Y, Doogan S, Irizarry M, et al
    Stakeholder Insights in Alzheimer's Disease: Natural Language Processing of Social Media Conversations.
    J Alzheimers Dis. 2022 Jul 30. pii: JAD220422. doi: 10.3233/JAD-220422.
    >> Share

    J Neurochem

  19. GALGANI A, Vergallo A, Campese N, Lombardo F, et al
    Biological determinants of blood-based cytokines in the Alzheimer's Disease clinical continuum.
    J Neurochem. 2022 Aug 11. doi: 10.1111/jnc.15686.
    >> Share

  20. DEVINA T, Wong YH, Hsiao CW, Li YJ, et al
    Endoplasmic reticulum stress induces Alzheimer's disease-like phenotypes in the neuron derived from the induced pluripotent stem cell with D678H mutation on amyloid precursor protein.
    J Neurochem. 2022 Aug 9. doi: 10.1111/jnc.15687.
    >> Share

    J Neurol

  21. ALTUNA M, Larumbe R, Zelaya MV, Moreno S, et al
    Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization.
    J Neurol. 2022;269:4853-4862.
    >> Share

  22. RHODUS EK, Barber J, Kryscio RJ, Abner EL, et al
    Frontotemporal neurofibrillary tangles and cerebrovascular lesions are associated with autism spectrum behaviors in late-life dementia.
    J Neurol. 2022;269:5105-5113.
    >> Share

  23. ACHENBACH J, Faissner S, Saft C
    Resurrection of sildenafil: potential for Huntington's Disease, too?
    J Neurol. 2022;269:5144-5150.
    >> Share

    J Neurol Neurosurg Psychiatry

  24. O'CONNOR A, Abel E, Benedet AL, Poole T, et al
    Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
    J Neurol Neurosurg Psychiatry. 2022 Aug 10. pii: jnnp-2022-329663.
    >> Share

  25. BARBA L, Abu Rumeileh S, Bellomo G, Paolini Paoletti F, et al
    Cerebrospinal fluid beta-synuclein as a synaptic biomarker for preclinical Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2022 Aug 9. pii: jnnp-2022-329124.
    >> Share

    J Neurosci

  26. GUO T, Pan X, Jiang G, Zhang D, et al
    Downregulating PTBP1 fails to convert astrocytes into hippocampal neurons and to alleviate symptoms in Alzheimer's mouse models.
    J Neurosci. 2022 Aug 9. pii: JNEUROSCI.1060-22.2022.
    >> Share


  27. DEPEW R
    To My Husband With Alzheimer Disease.
    JAMA. 2022;328:587.
    >> Share

    Nat Med

  28. MILA-ALOMA M, Ashton NJ, Shekari M, Salvado G, et al
    Plasma p-tau231 and p-tau217 as state markers of amyloid-beta pathology in preclinical Alzheimer's disease.
    Nat Med. 2022 Aug 11. pii: 10.1038/s41591-022-01925.
    >> Share

    Nat Rev Neurol

  29. PANZA F, Lozupone M
    The challenges of anti-tau therapeutics in Alzheimer disease.
    Nat Rev Neurol. 2022 Aug 8. pii: 10.1038/s41582-022-00702.
    >> Share


  30. FROLICH L, Hausner L
    [Erratum to: Disease-modifying treatment approaches for Alzheimer's disease].
    Nervenarzt. 2022 Aug 12. pii: 10.1007/s00115-022-01366.
    >> Share

    Neurobiol Aging

  31. GRAFF-RADFORD J, Mielke MM, Hofrenning EI, Kouri N, et al
    Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's disease.
    Neurobiol Aging. 2022;119:1-7.
    >> Share

    Neurochem Res

  32. LUO JS, Ning JQ, Chen ZY, Li WJ, et al
    The Role of Mitochondrial Quality Control in Cognitive Dysfunction in Diabetes.
    Neurochem Res. 2022;47:2158-2172.
    >> Share

  33. WANG X, Li B, Yu X, Zhou Y, et al
    The Neuroprotective Effect of GM-1 Ganglioside on the Amyloid-Beta-Induced Oxidative Stress in PC-12 Cells Mediated by Nrf-2/ARE Signaling Pathway.
    Neurochem Res. 2022;47:2405-2415.
    >> Share

  34. IBI D, Kondo S, Ohmi A, Kojima Y, et al
    Preventive Effect of Betaine Against Cognitive Impairments in Amyloid beta Peptide-Injected Mice Through Sirtuin1 in Hippocampus.
    Neurochem Res. 2022;47:2333-2344.
    >> Share

    Neurologia (Engl Ed)

  35. PUIG-PIJOAN A, Garcia-Escobar G, Fernandez-Lebrero A, Manero Borras RM, et al
    The CORCOBIA study: Cut-off points of Alzheimer's disease CSF biomarkers in a clinical cohort.
    Neurologia (Engl Ed). 2022 Aug 9. pii: S2173-5808(22)00084.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016